Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, Campus Universitário Darcy Ribeiro, University of Brasilia, 70910-900 Brasilia, Distrito Federal, Brazil.
Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, Campus Universitário Darcy Ribeiro, University of Brasilia, 70910-900 Brasilia, Distrito Federal, Brazil.
Int J Pharm. 2022 Jan 25;612:121367. doi: 10.1016/j.ijpharm.2021.121367. Epub 2021 Dec 10.
One of the main obstacles in the treatment of neurological diseases, perhaps the biggest one, is the delivery of therapeutic compounds to the central nervous system, and nanoparticles are promising tools to overcome this challenge. Different types of nanoparticles may be used as delivery systems, including liposomes, carbon nanotubes, and dendrimers. Nevertheless, these nanoparticles must display characteristics to be useful in brain drug delivery, such as stability, permeability to blood vessels, biocompatibility, and specificity. All of these aspects are intrinsically related to the physicochemical properties of nanoformulations: size, composition, electric charge, hydrophobicity, mucoadherence, permeability to the blood-brain barrier, and many others. Furthermore, there are challenging hindrances involved in the development and application of nanoparticles - hence the importance of studying and understanding these pharmaceutical tools.
在神经疾病的治疗中,一个主要障碍(也许是最大的障碍)是将治疗化合物递送到中枢神经系统,而纳米颗粒是克服这一挑战的有前途的工具。不同类型的纳米颗粒可被用作递药系统,包括脂质体、碳纳米管和树枝状大分子。然而,这些纳米颗粒必须表现出一些特性,才能在脑部药物递送中有用,例如稳定性、对血管的通透性、生物相容性和特异性。所有这些方面都与纳米制剂的理化性质内在相关:大小、组成、电荷、疏水性、黏膜黏附性、对血脑屏障的通透性,以及许多其他方面。此外,纳米颗粒的开发和应用还存在着具有挑战性的障碍,因此研究和理解这些药物工具非常重要。